pharmaphorum

NOVEMBER 24, 2022

Two years ago, the EMA proposed a set of recommendations to unlock the potential of big data for public health, headlined by the creation of a platform to access and analyse healthcare data from across the bloc. With the first data partners on board, the regulator can now move ahead with the start of its first studies.

Big Data 52

Big Data Biobanking Regulation Medicine 52

pharmaphorum

JUNE 28, 2016

In today’s competitive, highly regulated environment, product success is dependent upon data and fact-based decision making. More and more, Medical Affairs teams play a pivotal role in education pre- and post-launch, yet the explosion of big data in healthcare is changing how we make value-based decisions that are critical to success.

Compliance 52

Compliance Big Data Regulation Production 52

Roots Analysis

APRIL 4, 2023

In addition to the advances in processing power of computing machines and the development of smarter algorithms, big data is considered to be one of the key drivers of growth in this segment. Big data holds great promise in terms of its potential applications in the healthcare industry as mentioned below.

Big Data 52

Big Data Life Science Development Clinical Trials 52

ACRP blog

APRIL 5, 2023

Through these collaborations, advanced technologies tied to AI and big data are being employed to develop personalized and targeted medicines, ultimately leading to more effective treatments for diseases like cancer and immune deficiencies,” Lyons notes.

Clinical Trials 52

Clinical Trials Clinical Trials Big Data Life Science 52

pharmaphorum

JULY 14, 2022

A pilot study has been launched by the EMA to see whether it is helpful for regulators to look at the ‘raw data’ from clinical trials submitted in support of new marketing application along with the usual structured analyses from sponsors. It may also help the regulator to define target treatment populations better.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Regulation 52

pharmaphorum

FEBRUARY 1, 2022

The impact of big data, artificial intelligence and machine learning. Our mission is to convene a community of collaboration and best practice around the practical application of RWE in rare diseases and innovative therapies, so the event will bring together exciting formats to encourage conversation, collaboration and action.

Big Data 59

Big Data Regulation 59

pharmaphorum

JANUARY 24, 2022

AI in drug discovery is becoming an integral part of the research and development area of treating diseases with more companies incorporating ‘Big Data’ and data scientists within their R&D teams. Engage with regulators about the guidance within machine learning and AI in Drug Discovery.

Drugs 52

Drugs Big Data Scientist Clinical Trials 52

Pharma Marketing Network

JANUARY 29, 2025

With machine learning and big data analytics, companies can now predict market trends, enhance drug development, and create hyper-personalized campaigns. Big data analytics plays a crucial role in identifying prescribing patterns, understanding patient behaviors, and tailoring content strategies.

Marketing 52

Marketing Compliance Big Data Branding 52

Pharma Marketing Network

JANUARY 9, 2025

Big Data: Data-driven insights guide targeted advertising and refine messaging for different audience segments. Adapting to Regulatory Changes and Compliance In an industry as tightly regulated as pharma, staying compliant isnt just a checkboxits a necessity. How can technology enhance pharma marketing strategies?

Marketing 52

Marketing Compliance Big Data Regulation 52

Pharma Marketing Network

MAY 6, 2023

Additionally, AI-generated content can be difficult to regulate, which can result in the spread of false or misleading information. Weapons of Math Destruction: How Big Data Increases Inequality and Threatens Democracy.” 1) Danks, D. “AI AI Ethics: The Importance of Fairness.” Harvard Business Review, vol. 7/8, 2018, pp.

Marketing 52

Marketing Big Data Regulation 52

Cloudbyz

SEPTEMBER 3, 2024

With the ability to process and analyze vast amounts of data from various sources, pharmacovigilance professionals can now identify potential safety signals earlier and more accurately, leading to timely interventions and better patient outcomes.

Compliance 52

Compliance Big Data Clinical Trials Clinical Trials 52

pharmaphorum

JULY 4, 2022

Together, the webinar panellists explored the potential of medical informatics solutions and methods in rare disease research, studies, data optimisation, and usability to overcome these challenges, all whilst maintaining compliance with data protection regulations and a patient-centric approach.

Genome 105

Genome Genomics Research Medicine 105

pharmaphorum

DECEMBER 22, 2021

Rise of the machines – big data, AI and machine learning. Companies will capitalise on tech advances in the areas of data use to inform R&D and/or provide personalised care to patients. Patients are beginning to expect the providers of their medicines to help them with their condition and the impact on their lives.

Clinical Trials 105

Clinical Trials Clinical Trials Trials Pharma Companies 105

pharmaphorum

FEBRUARY 16, 2021

Consequently, the commercial teams would never have access to the detailed R&D data or the production data, making it impossible to have an end-to-end management of the product life cycle based on a common dataset. Once we combine data-driven and human behavioural insights, we can really understand what we can do.

Marketing 107

Marketing Production Big Data Pharma Companies 107

Pharma Marketing Network

OCTOBER 17, 2024

Data-Driven Strategies for Enhanced Engagement In the era of big data, pharmaceutical companies are harnessing the power of data-driven strategies to enhance engagement with both healthcare professionals and patients. One major area of regulatory change is the emphasis on patient data protection.

Marketing 52

Marketing Pharma Companies Regulation Production 52

XTalks

APRIL 5, 2021

Furthermore, the necessary knowledge and understanding of research requirements, regulations and protocols to comply with all federal rules is an asset. This job entails combining scientific information with computational information from databases to make sense of big data. Bioinformatics Analyst Salary.

Bioinformatics 59

Bioinformatics Engineer Scientist Genome 59

Delveinsight

FEBRUARY 17, 2021

The government also needs to bring strict and standard legislation and regulations to deal with data breaches in healthcare and other sectors. . Companies and healthcare providers need to invest in cybersecurity and similarly need to train the staff. Healthcare Mobile Apps (Medical mobile applications).

Doctors 52

Doctors Doctor Big Data Development 52

The Pharma Data

JANUARY 4, 2021

” Kiromic’s DIAMOND is big data science meeting target identification, dramatically compressing man-years and billions of drug development dollars to develop a live drug. relevant government policies and regulations relating to our industry. Kiromic BioPharma, Inc.

In-Vivo 40

In-Vivo Development Immune Response Big Data 40

The Pharma Data

OCTOBER 25, 2020

BTI’s drug re-innovation approach leverages existing approved drugs and/or clinically evaluated product candidates together with big data and proprietary machine learning algorithms to identify new therapeutic indices. BioXcel Therapeutics, Inc.

Trials 40

Trials Production FDA Approval Development 40

Pharma Marketing Network

JUNE 11, 2020

Big Data was a critical topic. I mean, every aspect of the industry from FDA approvals and regulations to the actual nuts and bolts of marketing and what works and what doesn’t work. And we really want to be as inclusive as we can be. We sat down, we said, well, what are the critical topics we want to talk about?

Marketing 52

Marketing Branding Regulation Production 52

XTalks

AUGUST 2, 2023

In September 2022, Roche acquired Good Therapeutics for an upfront payment of $250 million, and has access to their PD-1-regulated IL-2 program. The TPO receptor agonist regulates blood platelet production by binding to and activating TPO receptors on megakaryocyte cells and inducing signalling cascades that increase platelet production.

Sales 98

Sales Manufacturing FDA Approval Life Science 98

pharmaphorum

MARCH 16, 2021

Savana’s platform guarantees patient safety through de-identified, anonymised data and a statistical model called Natural Privacy. It’s a statistical model, which by design, guarantees confidentiality and satisfies the requirements of Hospital ethics committees, NHS regulations and Life Science industry policies.

Doctor 116

Doctor Doctors Life Science Clinical Research 116

Pharmaceutical Technology

JUNE 20, 2023

The current tech landscape is rapidly evolving, with advancements in areas such as big data and conversational platforms. Big data is essentially extremely large data sets that can be analysed to reveal patterns, trends, and associations, especially relating to human behaviour and interactions.

Life Science 130

Life Science Clinical Trials Clinical Trials Regulation 130

Pharmaceutical Technology

FEBRUARY 16, 2023

Stringent government regulations and the growing need for uncompromised quality have further encouraged demand. It has prompted the demand and adoption of analysis and test & measurement equipment solutions in the pharmaceutical end-use industries.

Engineer 130

Engineer Manufacturing Containment Production 130